跳至主要内容
临床试验/NCT02469103
NCT02469103已完成不适用

The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis

Chinese University of Hong Kong2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2014年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
2
主要终点
Number of participants with extent and severity of colonic inflammation

研究概览

简要总结

The purpose of this study is to investigate the accuracy of second generation colon capsule (C2) in evaluating colonic mucosal inflammation of ulcerative colitis patients, using conventional endoscopy as the gold standard.

详细描述

Consecutive patients with ulcerative colitis will be recruited. Second generation colon capsule endoscopy (C2) and conventional colonoscopy will be performed one after another on the same day. Colonic mucosal inflammation will be scaled by physicians who review C2 videos and those who perform conventional colonosocpies independently. Physicians who review C2 videos and colonoscopists will be blinded to the findings of colonoscopies and C2 videos, respectively.The accuracy of C2 in evaluating mucosal inflammation will be evaluated, using conventional endoscopy as the gold standard.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18-80 years
  • suspected or known UC
  • written informed consent

排除标准

  • patients with severe UC according to Truelove and Witts' criteria
  • current pregnancy/lactating
  • patients with a pacemaker or other implanted electromedical device
  • the presence of dysphagia
  • patients at higher risk of capsule retention (including Crohn's disease, small bowel tumor, radiation enteropathy, previous intestinal surgery, acute abdominal pain without regular defecation)
  • patients with a contraindication to bowel preparation (congestive heart failure, renal insufficiency, a life-threatening condition)
  • patients with an allergy to polyethylene glycol, sodium phosphate solution, metoclopramide or bisacodyl suppository

研究组 & 干预措施

C2 & colonoscopy

Experimental

C2 and colonoscopy

干预措施: colonoscopy (Procedure)

C2 & colonoscopy

Experimental

C2 and colonoscopy

干预措施: C2 (Device)

结局指标

主要结局

Number of participants with extent and severity of colonic inflammation

时间窗: 1 day

extent and severity of mucosal inflammation will be assessed by each investigation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Siew Chien NG

Professor

Chinese University of Hong Kong

研究点 (2)

Loading locations...

相似试验